Literature DB >> 6137140

Drug interactions with amiodarone.

F I Marcus.   

Abstract

There are a number of important drug interactions with amiodarone. This agent appears to have a marked effect on the kinetics of some commonly used cardiovascular drugs, such as warfarin, digoxin, quinidine, and procainamide, and has dynamic interactions with others, such as the beta blockers and some calcium antagonists. Bleeding has been reported, apparently caused by a potentiation of the anticoagulant effect of warfarin by amiodarone. Torsades de pointes has been observed when quinidine, propafenone, or mexiletine is given together with amiodarone. Furthermore, amiodarone may interact with beta-blocking agents and some of the calcium antagonists to produce symptomatic sinus bradycardia and sinus arrest, especially in a latent or overt sick sinus syndrome. During surgery, amiodarone may induce hypotension and an atropine-resistant bradycardia, possibly by interacting with anesthetic agents. A knowledge of the time of onset, extent, duration, and possible mechanisms of the interactions of amiodarone with other cardioactive drugs is still incomplete, but further studies are of great therapeutic importance.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6137140     DOI: 10.1016/0002-8703(83)90017-0

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  23 in total

1.  Pharmacological cardioversion of recent onset atrial fibrillation with intravenous amiodarone in patients receiving long-term amiodarone therapy: is it reasonable?

Authors:  Emmanuel M Kanoupakis; George E Kochiadakis; Emmanuel G Manios; Nikolaos E Igoumenidis; Hercules E Mavrakis; Panos E Vardas
Journal:  J Interv Card Electrophysiol       Date:  2003-02       Impact factor: 1.900

2.  Continuous spinal anaesthesia for abdominal surgery in a patient receiving amiodarone.

Authors:  D J Kopacz
Journal:  Can J Anaesth       Date:  1991-04       Impact factor: 5.063

3.  Sudden hypothyroidism and amiodarone-lithium combination: an interaction.

Authors:  S Ahmad
Journal:  Cardiovasc Drugs Ther       Date:  1995-12       Impact factor: 3.727

Review 4.  Potentially significant drug interactions of class III antiarrhythmic drugs.

Authors:  Weeranuj Yamreudeewong; Michael DeBisschop; Linda G Martin; Dennis L Lower
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

5.  Methotrexate induced skin necrosis: a drug interaction with amiodarone?

Authors:  N J Reynolds; S K Jones; J Crossley; R R Harman
Journal:  BMJ       Date:  1989-10-14

6.  Agreement among four drug information sources for the occurrence of warfarin drug interactions in Brazilian heart disease patients with a high prevalence of Trypanosoma cruzi infection.

Authors:  Maria A P Martins; Daniel D Ribeiro; Vandack A Nobre; Fabiana R Pereira; Cibele C César; Manoel O C Rocha; Antonio L P Ribeiro
Journal:  Eur J Clin Pharmacol       Date:  2012-09-28       Impact factor: 2.953

7.  Combined anti-arrhythmic therapy with class 1 and class 3 drugs.

Authors:  M A James; P Papouchado; J V Jones
Journal:  Postgrad Med J       Date:  1989-08       Impact factor: 2.401

Review 8.  Clinical pharmacokinetics of amiodarone.

Authors:  R Latini; G Tognoni; R E Kates
Journal:  Clin Pharmacokinet       Date:  1984 Mar-Apr       Impact factor: 6.447

Review 9.  Clinical pharmacokinetics of the newer antiarrhythmic agents.

Authors:  A M Gillis; R E Kates
Journal:  Clin Pharmacokinet       Date:  1984 Sep-Oct       Impact factor: 6.447

10.  Amiodarone-induced thyrotoxicosis: is there a place for surgery?

Authors:  M Meurisse; E Hamoir; M D'Silva; J Joris; G Hennen
Journal:  World J Surg       Date:  1993 Sep-Oct       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.